Current News

Contact | Print version | PDF version | Send article | RSS-Feed

elbion AG appoints Dr. Thomas Taapken as Chief Financial Officer and Member of the Executive Board

23 Sep 2005 - elbion AG announced that Dr. Thomas Taapken has been appointed Chief Financial Officer by the supervisory board of the company.
 
Taapken (40), previously spent 3 years as a Partner in the life science team of DVC, Deutsche Venture Capital, and was a member of the supervisory board of elbion AG. He has resigned from DVC, and has also stepped down from his position as a supervisory board member of the company, to join elbion's management board. Prior to his position at DVC, Thomas Taapken worked for 8 years at Sanofi-Aventis in the areas of research, corporate development and venture capital. In his last position he held responsibility for the corporate venture capital activities of the group. Dr. Taapken holds a PhD in chemistry from the Technical University of Berlin.